Low-dose oral contraceptives: health consequences of discontinuation
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Contraception
- Vol. 62 (6) , 285-288
- https://doi.org/10.1016/s0010-7824(00)00179-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparationsContraception, 1999
- A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 μg levonorgestrel with 20 μg ethinyl estradiol or triphasic norethindrone with ethinyl estradiolAmerican Journal of Obstetrics and Gynecology, 1999
- Cycle control with oral contraceptives containing 20 μg of ethinyl estradiol: A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 μg/20 μg) and norethindrone/ethinyl estradiol (1000 μg/20 μg)Contraception, 1999
- Compliance and oral contraceptives: A reviewContraception, 1995
- The new low dose oral contraceptivesJournal of Obstetrics and Gynaecology, 1994
- Oral contraceptives and cycle control: A critical review of the literatureAdvances in Contraception, 1992
- Interchangeability of low-dose oral contraceptives: Are current bioequivalent testing measures adequate to ensure therapeutic equivalency?Contraception, 1991
- Adolescent contraception: An overviewAdolescent and Pediatric Gynecology, 1988
- What Do Women Use When They Stop Using the Pill?Family Planning Perspectives, 1987
- Generic drugs and the prescribing physicianPublished by American Medical Association (AMA) ,1987